NEW YORK, July 9, 2019 /PRNewswire/ -- Elsevier, the global information analytics business specializing in science and health, has announced that it is expanding its R&D start-up innovation program called The Hive to include engineering-intensive start-ups. Participants in The Hive will be provided complimentary access to Elsevier's suite of engineering solutions to help them accelerate the route to market for new innovations. Applications and nominations for The Hive are now open.
Elsevier first launched The Hive in 2016 to highlight the superior levels of innovation in the start-up biotech and pharma sector—and to provide early stage companies with resources to overcome R&D challenges. Engineering-intensive companies face equally complex challenges: Across all industries, software and digital technologies are putting pressure on engineering teams to transform their practices; become more agile; reduce time to market of new products; and work more openly with external partners.
"The role of the engineer continues to evolve rapidly," said Sumita Singh, Managing Director for Reference Solutions, Elsevier. "Modern engineers spend 40-50 percent of their time searching for trusted information and insights to do their jobs."
To help engineers face these critical challenges, Elsevier is offering complimentary access to its digital solutions purpose-built to help solve engineering problems, including Knovel a technical reference solution that quickly delivers trusted, accessible and relevant engineering answers & insights; and Engineering Village, the world's largest engineering literature resource with access to 12 databases and over 190 engineering disciplines. Elsevier's leading abstract and citation database, Scopus (with the option to receive access to other products, such as ScienceDirect), will also be made available for a select group of companies.
"Engineers must interpret a wide range of data sources including unstructured data, sensor data and connected devices. To excel in their roles, engineers need access to the trusted, comprehensive and easy-to-use digital solutions that provide engineering information at their fingertips, helping them to develop new protocols and products as safely and efficiently as possible." Singh added.
"Tools like Knovel and Engineering Village have been designed to work together to support an engineer's workflow and are already well known in large R&D organizations and in academe. With The Hive, we want to expand access for smaller, start-up organizations by giving them the opportunity to become familiar with these tools and extract the needed value to address the weighty challenges they face."
Companies eligible for The Hive will need to meet the following criteria:
- Is in one of the following industries:
o Chemicals and materials
o Oil & Gas
o Equipment Manufacturing
o Aerospace & Defense (including Transportation)
o Engineering, Construction, and Design
- Is not currently seeking to be acquired.
- Is a small-to-medium-sized company, with its engineers and researchers in 1-2 locations.
If your company is interested in joining Elsevier's The Hive, please apply today.
About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Media contact
Christopher Capot, Global Communications
Elsevier
+1-917-704-5174
[email protected]
SOURCE Elsevier
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO07468&Transmission_Id=201907090901PR_NEWS_USPR_____IO07468&DateId=20190709)
Share this article